ArticleESMO open2022

Methylation subgroup and molecular heterogeneity is a hallmark of glioblastoma: implications for biopsy targeting, classification and therapy.

J Gempt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.